CLINICAL_TRIALS
research
· 2014-02-11
Clinical Trial Update: Safety Study of Dabigatran in CADASIL [Phase 2]
Summary
Phase 2 safety study of the anticoagulant dabigatran in CADASIL, with the trial status listed as Unknown.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: S. Andrea Hospital | Conditions: CADASIL | Phase 2 | Status: UNKNOWN